At Rdcthera, we have enviable expertise in CRO services that cater to all the special requirements radiopharmaceuticals may have. Our in vitro metabolite analysis services are specifically designed for developing and optimizing radiopharmaceuticals in aspects of safety, efficacy, and compliance. Having seasoned scientists powered by state-of-the-art equipment and cutting-edge technologies, Rdcthera is hell-bent on ensuring that the advancement of radiopharmaceuticals finds a foothold on the pedestal of robust and precise metabolite analysis.
Metabolic pathways of radiopharmaceuticals are keys to their function and safety. Metabolite analysis gives insight into possible routes of metabolism that the radiotracer may follow in vivo. This should therefore be done to validate the choice of labeling position, such as in brain tracers where the radionuclide should stay within hydrophilic metabolites. This metabolite analysis identifies points of weakness in the tracer structure, where refinement is needed to enhance its stability and efficiency.
Fig. 1. Metabolite analysis process. (Chen Y, et al., 2022)
At Rdcthera, we offer end-to-end metabolite analysis services for radiopharmaceuticals. These main studies in metabolic pathways will be realized in organs responsible for the metabolism of the tracer in target tissue/cell populations themselves or within cell cultures and tissue homogenates. All these processes provide very important information about the status and fate of tracers.
State-of-the-art analytic techniques distinguish the tracers from their metabolites. Good care is taken to account for the metabolic decay of the tracer and eliminate possible interfering factors. The rigor of the approach ensures that the metabolic data generated are both reliable and accurate.
Clients can look forward to getting information, data, and insights into our metabolite analysis, which will provide details on metabolic transformations the tracers take, possible weaknesses of structures, and their postmetabolic fate. Such insights should be crucial in the development of safe and effective diagnostic and therapeutic radiopharmaceutical formulations.
Metabolite analysis will find extensive application in radiopharmaceutical development. The study of metabolic pathways will be very instrumental in the structural optimization of tracers, their in vivo stability assessment, and proof of the safety and efficacy of those molecules. Rdcthera provides metabolite analysis services as a mainstay for the advancement of research and development in this field.
Please do not hesitate to contact us if you need any further information on metabolite analysis services for radiopharmaceuticals.
Reference
Rdcthera offers efficient, customized, and professional R&D services related to radionuclide drug conjugates.